Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - Australia

Australia

Revenue in the Sleep Aids market amounts to €20.44m in 2024. The market is expected to grow annually by 6.14% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,950m in 2024).
In relation to total population figures, per person revenues of €0.77 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Sleep Aids market in Australia has been experiencing steady growth in recent years.

Customer preferences: Customers in Australia are increasingly seeking sleep aids to help them combat sleep disorders and improve the quality of their sleep. This trend is driven by several factors, including the growing awareness of the importance of sleep for overall health and well-being. Additionally, the high-stress lifestyles and long working hours of many Australians have contributed to a rise in sleep-related issues, leading to an increased demand for sleep aids.

Trends in the market: One of the key trends in the Sleep Aids market in Australia is the growing popularity of natural and herbal sleep aids. Many consumers are opting for these products due to concerns about the potential side effects of prescription sleep medications. The demand for natural sleep aids is also driven by the increasing preference for organic and natural products in the overall health and wellness industry. Another trend in the market is the rising popularity of wearable sleep trackers and smart devices that monitor sleep patterns. These devices provide valuable insights into sleep quality and help individuals identify and address sleep issues. The integration of technology into sleep aids has made them more accessible and convenient for consumers, further driving market growth.

Local special circumstances: Australia has a high prevalence of sleep disorders, with approximately one in three adults experiencing some form of sleep problem. This high incidence rate has created a significant market opportunity for sleep aids in the country. Additionally, the aging population in Australia has also contributed to the growth of the Sleep Aids market, as older adults are more prone to sleep disturbances and seek solutions to improve their sleep quality.

Underlying macroeconomic factors: The Sleep Aids market in Australia is also influenced by several macroeconomic factors. The country's strong economy and high disposable income levels have contributed to increased consumer spending on health and wellness products, including sleep aids. Additionally, the growing trend of self-care and the focus on mental health and well-being have also played a role in driving the demand for sleep aids. In conclusion, the Sleep Aids market in Australia is experiencing growth due to customer preferences for natural and herbal sleep aids, the popularity of wearable sleep trackers, and the high prevalence of sleep disorders in the country. The local special circumstances, such as the aging population and high-stress lifestyles, further contribute to the market's growth. The underlying macroeconomic factors, including the strong economy and focus on health and wellness, also play a significant role in driving the market forward.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.